News

"We now understand how this complicated assembly process works."

Scientists from the Florida campus of The Scripps Research Institute have identified a class of compounds that significantly delays the onset of several age-related symptoms

"Clearly, there is an urgent need to develop better options for these patients."

One new assistant and one new associate professor to join the institute’s La Jolla and Jupiter campuses, respectively.

Researchers have developed a test that will help scientists identify new drug candidates for treating pain that have fewer side effects, like addiction.

Two new studies led by scientists at Scripps Research could guide future therapies to improve health and lifespan.

"It is one of the most productive large-scale science grants that NIAID funds."

New method provides researchers with a new way to understand such drug compounds, especially where individual components or metabolites interact to produce the complete effects of psychoactive species.

The five-year award provides general, long-term support for research programs that are deemed especially promising.

Staff Scientist Kathryn Hastie of The Scripps Research Institute (TSRI) has won the 2017 William E. and Diane M. Spicer Young Investigator Award.

Annual Nature Index supplement ranks research institutes on influence over scientific patents.

Scientists at The Scripps Research Institute have developed a highly efficient new method for making ribonucleic acid (RNA) molecules in the laboratory.

Scripps Research study of interferon gamma reveals new principle of cell signaling.

These new findings provide the first molecular understanding of the pathology of the disease known as Diamond-Blackfan anemia.

Scientists at Scripps Research have invented a versatile method for identifying proteins that can feasibly be targeted with drugs to treat disease.

Future studies will attempt to explain the biological significance of these two distinct cell types competing for a shared source of survival stimuli.

In their study, the researchers injected HIV immunogens into the flanks of four calves and waited for their immune systems to respond.

Atomic-scale snapshot reveals new regions on HIV’s envelope trimer protein that could be targets for small molecule inhibitor development.

A team of scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded nearly $2 million from the National Institute of Mental Health of the National Institutes of Health.

Mice in new Scripps Research study sprinted faster but had less endurance over longer distances.

Scientists have a long way to go to fully understand how our brains forget unused and unimportant memories and make space for new ones.

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

Scripps Research scientists have improved a state-of-the-art gene-editing technology to advance the system’s ability to target, cut and paste genes within human and animal cells.

"The new grant supports the idea that RNA is a legitimate target to treat disease."